Future Equity Clause Samples
POPULAR SAMPLE Copied 1 times
Future Equity. The recipient affirmatively waives any right to any future equity or equity-based interests in Kindly MD, Inc., N▇▇▇▇▇▇▇ Holdings Inc, or any of their respective subsidiaries or affiliates.
Future Equity. You may be eligible for future equity grants as determined by and pursuant to the terms established by the Compensation Committee. The amount and performance metrics for subsequent performance-based restricted stock units will be determined by the Compensation Committee.
Future Equity. You shall be eligible for future equity grants as determined by and pursuant to the terms established by the Compensation Committee.
Future Equity. After the Initial Term, Executive shall be eligible for future equity grants, in the discretion of the Board (or its Compensation Committee).
Future Equity. Executive will be eligible to receive awards of stock options, restricted stock or other equity awards pursuant to any plans or arrangements the Company may have in effect from time to time. The Board or the Compensation Committee will determine in its discretion whether Executive will be granted any such equity awards and the terms of any such award in accordance with the terms of any applicable plan or arrangement that may be in effect from time to time. All of Executive’s stock option agreements will permit or, subject to approval by the Board, the Compensation Committee or their authorized committee or delegate, will be amended pursuant to this Agreement to permit, as applicable, exercise of Executive’s stock options by means of a “net exercise.”
Future Equity. Employee hereby waives, cancels and terminates any ------------- right to receive any additional equity or securities in the Company or related entities.
Future Equity. During the term of Executive’s employment under this Agreement, Executive also shall be eligible to participate in stock option and equity plans and grants, if any, that are offered to senior executive/officer employees of the Company, as determined by the Compensation Committee and approved by the Board from time to time.
Future Equity. Subject to the Shareholder Approval, following the Tranche 2 Closing, as the Company from time-to-time issues equity or equity-convertible securities, Company shall sell to Sponsor securities (whether in the form of Ordinary Shares or such other equity or equity-convertible securities as sold by the Company), representing that number of Ordinary Shares (on a fully-diluted, as converted basis), at a price per Ordinary Share equal to the Per Security Price, that is equal to five percent (5%) of the total number of Ordinary Shares (on a fully-diluted, as converted basis) as have been or are being issued by the Company (whether as Ordinary Shares or other securities convertible, exchangeable or otherwise exercisable into Ordinary Shares) from the date of the later of the Tranche 1 or the Tranche 2 Closing (or, as applicable, the last sale by the Company to Sponsor pursuant to this Section 3.1(c)) through to and including the date on which securities are sold to the Sponsor pursuant to this Section 3.1(c); provided that there shall not be any duplicated issuances that may occur pursuant to Sections 3.1(b) and 3.1(c). Securities sold to the Sponsor pursuant to this Section 3.1(c) will be sold in the same form and mix at which such securities are issued by the Company to third parties (so that if, for example, the Company conducts an offering of Ordinary Shares with 50% warrant coverage, the securities to be sold to Sponsor as a result of that offering would consist of Ordinary Shares with 50% warrant coverage on the same warrant terms); provided, however, that Ordinary Shares shall instead be issued in the form of pre-funded warrants, the form of which is set forth in Exhibit B hereto to the extent that, if issued as Ordinary Shares, they would cause the Sponsor to exceed a beneficial ownership of greater than 4.99% of the Customer. The closing of sales of Ordinary Shares pursuant to this Section 3.1(c) shall be:
a. As part of, and within three (3) Business Days (as defined below) of, the closing of any sale of securities (a “Future Financing”) by the Company with gross proceeds exceeding ten million U.S. Dollars (U.S.$10 million); and
b. With respect to any other issuances of securities by the Company during a fiscal quarter that ends after the Tranche 2 Closing, on the third (3rd) Business Day (as defined in the Tranche 1 SPA) following the last day (or closest Business Day on which business is commonly transacted in both Israel and the United States) of such ...
Future Equity. The company acknowledges and agrees that this Agreement shall in no way effect Employee's rights pursuant to Section 4(d) of the Employment Agreement to receive as a bonus Equity Fees received by the Company after January 1, 2000 and prior to the Termination Date.
Future Equity. Executive will be eligible to receive awards of stock options, restricted stock or other equity awards pursuant to any plans or arrangements the Company may have in effect from time to time. The Board or the Compensation Committee will determine in its discretion whether Executive will be granted any such equity awards and the terms of any such award in accordance with the terms of any applicable plan or arrangement that may be in effect from time to time. All of Executive’s current and future stock option agreements will permit or, subject to approval by the Board or the authorized committee or delegate of the Board, will be amended pursuant to this Agreement to permit, as applicable, exercise of Executive’s stock options by means of a “net exercise”. All of Executive’s current and future stock options that are granted prior to a Change in Control or the closing of the Company’s first bona fide, firm commitment underwritten initial public offering pursuant to an effective registration statement filed under the Securities Act of 1933, as amended, covering the offer and sale of the Company’s common stock, shall permit early exercise of Executive’s unvested stock options. As of the Effective Date and to the extent Executive’s Equity Awards do not already so provide, this Agreement acts as an amendment to each of Executive’s Equity Awards that are outstanding as of the Effective Date. To the extent not amended by this Agreement, the terms and conditions of such Equity Awards remain in full force and effect. To the extent not already provided, Executive’s outstanding stock option agreements shall be amended to permit net exercise and early exercise, as applicable. Each early exercisable option shall be subject to the terms and conditions of an early exercise stock option agreement (or amendment to and/or restatement of currently outstanding option agreement, as applicable) and related attachments that shall be approved by the Board (or authorized committee or delegate of the Board).
